Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-inflammatory agent 79 (compound 17q) is an isoquinolinone derivative-based HIF-1 inhibitor (IC50: 0.55 μM), effectively blocking HIF-1 signaling and promoting the degradation of HIF-1α. It inhibits synovial invasion and migration, as well as angiogenesis. In mouse inflammation models, Anti-inflammatory agent 79 effectively reduces foot swelling and arthritis and lowers levels of inflammatory factors and angiogenesis in vivo.

| Description | Anti-inflammatory agent 79 (compound 17q) is an isoquinolinone derivative-based HIF-1 inhibitor (IC50: 0.55 μM), effectively blocking HIF-1 signaling and promoting the degradation of HIF-1α. It inhibits synovial invasion and migration, as well as angiogenesis. In mouse inflammation models, Anti-inflammatory agent 79 effectively reduces foot swelling and arthritis and lowers levels of inflammatory factors and angiogenesis in vivo. |
| In vitro | Anti-inflammatory agent 79 (2.5-10 μM; 24 h) dose-dependently inhibits hypoxia-induced HIF-1α protein accumulation, reducing inflammatory responses. It suppresses cell invasiveness and enhances VHL-dependent HIF-1α degradation in human RA synovial cell lines. |
| In vivo | Administered as an anti-inflammatory agent, compound 79 (at doses of 30 mg/kg and 60 mg/kg; ip; every 2 days for a total of 16 days) reduced pathological damage in the ankle joints of rats with adjuvant-induced arthritis (AIA), decreased angiogenesis, and mitigated the inflammatory response. |
| Formula | C21H17NO2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.